Clinical Trial Update: Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial results for the fludarabine, cyclophosphamide, and rituximab regimen in chronic lymphocytic leukemia have been completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)
• Rituximab (rituximab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2012-12-31